We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-6.45%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$440M
AUM Growth
+$68.3M
Cap. Flow
+$121M
Cap. Flow %
27.55%
Top 10 Hldgs %
7.16%
Holding
1,009
New
355
Increased
190
Reduced
143
Closed
321

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$7.33M
2
AZN icon
AstraZeneca
AZN
+$3.83M
3
SPB icon
Spectrum Brands
SPB
+$3.54M
4
BNS icon
Scotiabank
BNS
+$3.5M
5
TSN icon
Tyson Foods
TSN
+$3.37M

Top Sells

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$3.48M
2
DOV icon
Dover
DOV
+$2.95M
3
TU icon
Telus
TU
+$2.82M
4
SYK icon
Stryker
SYK
+$2.58M
5
TTWO icon
Take-Two Interactive
TTWO
+$2.49M

Sector Composition

Rank Sector Weight
1 Healthcare 18.71%
2 Technology 17.25%
3 Industrials 13.57%
4 Financials 13.31%
5 Consumer Discretionary 12.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CENT icon
726
Central Garden & Pet Co
CENT
$2.78B
-6,995
Closed -$224K
CENX icon
727
Century Aluminum
CENX
$4.59B
-91,628
Closed -$675K
CFG icon
728
Citizens Financial Group
CFG
$31.2B
-8,708
Closed -$311K
CHE icon
729
Chemed
CHE
$7.02B
-528
Closed -$248K
CHTR icon
730
Charter Communications
CHTR
$18.7B
-1,011
Closed -$474K
CIB icon
731
Grupo Cibest SA
CIB
$22.7B
-9,918
Closed -$306K
CLDX icon
732
Celldex Therapeutics
CLDX
$3.35B
-8,052
Closed -$217K
CLX icon
733
Clorox
CLX
$12.9B
-2,906
Closed -$410K
CM icon
734
Canadian Imperial Bank of Commerce
CM
$112B
-19,147
Closed -$929K
CNO icon
735
CNO Financial Group
CNO
$5.07B
-19,470
Closed -$352K
COLM icon
736
Columbia Sportswear
COLM
$2.96B
-2,957
Closed -$212K
CPRT icon
737
Copart
CPRT
$27.2B
-17,776
Closed -$483K
CPRI icon
738
Capri Holdings
CPRI
$1.77B
-18,883
Closed -$774K
CPT icon
739
Camden Property Trust
CPT
$11.1B
-4,555
Closed -$613K
CRL icon
740
Charles River Laboratories
CRL
$13.4B
-4,954
Closed -$1.06M
CROX icon
741
Crocs
CROX
$6.36B
-16,238
Closed -$790K
CRS icon
742
Carpenter Technology
CRS
$26.6B
-10,062
Closed -$281K
CSGS
743
DELISTED
CSG Systems International
CSGS
-6,081
Closed -$363K
CUBE icon
744
CubeSmart
CUBE
$9.4B
-4,694
Closed -$201K
CVGW
745
DELISTED
Calavo Growers
CVGW
-6,813
Closed -$284K
CW icon
746
Curtiss-Wright
CW
$25.4B
-7,660
Closed -$1.01M
CYH icon
747
Community Health Systems
CYH
$419M
-295,746
Closed -$1.11M
CYTK icon
748
Cytokinetics
CYTK
$10.2B
-20,328
Closed -$799K
DENN
749
DELISTED
Denny's
DENN
-35,574
Closed -$309K
DIS icon
750
Walt Disney
DIS
$181B
-8,755
Closed -$826K

Similar funds

Campbell & Co Investment Adviser's Q3 2022 Portfolio in Review

As of Q3 2022, Campbell & Co Investment Adviser held 1,009 positions worth $440M, up 18% from $372M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Campbell & Co Investment Adviser deployed $121M of net new capital in Q3 2022, opening 355 new positions and adding to 190 existing holdings. Its largest new stake was GSK: 193,518 shares worth $5.7M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Dover, an estimated $2.95M trimmed.

  • Campbell & Co Investment Adviser's largest Q3 2022 buy was GSK: 193,518 shares worth $5.7M.
  • Campbell & Co Investment Adviser added most to Scotiabank in Q3 2022, an estimated $3.5M increase.
  • Campbell & Co Investment Adviser's biggest Q3 2022 reduction was Dover, cutting an estimated $2.95M.
  • Campbell & Co Investment Adviser fully exited Virtu Financial in Q3 2022, selling an estimated $3.48M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 7.2% of its $440M portfolio in Q3 2022.
  • Campbell & Co Investment Adviser opened 355 new positions and closed 321 in Q3 2022.
  • Campbell & Co Investment Adviser's portfolio value rose 18% quarter-over-quarter to $440M.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2022, filed 14 Nov 2022.